Dr. Nicole Urban

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Molecular Diagnostics Program
Public Health Sciences
MemberAppointed: 2005
Gynecologic Cancer Research Program
Fred Hutchinson Cancer Research Center
Program HeadAppointed: 2001
University of Washington
School of Public Health and Community Medicine
Health Services
Research ProfessorAppointed: 2000
Professional Headshot of Nicole Urban

Mailing Address

Molecular Diagnostics Program
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N
M2-B230
Seattle, Washington 98109
United States

Contact Information

Phone: (206) 667-4677
Fax: (206) 667-7264
nurban@fhcrc.org

Qualifications

Sc.D., 1978.
M.S., 1973.

Expertise and Research Interests

Ovarian cancer
Health economics
Cancer screening
Biomarkers
Breast cancer
Cost-effectiveness analysis
Mammography

Dr. Urban heads the Translational and Outcomes Research (TOR) group at Fred Hutchinson Cancer Research Center. TOR spans the process of discovery, development, and evaluation of targets and interventions to improve outcomes for individuals at risk for cancer. The translational component involves working closely with clinical as well as laboratory researchers, and with patientsas well as with healthy individuals. It involves comparative genomics and proteomics and the development of statistical methods to analyze gene expression and biomarker data. Our emphasis is on early detection and immunotherapy for prevention of cancer and/or recurrence of cancer, particularly ovarian and breast cancer. The outcomes component emphasizes modeling and cost-effectiveness analysis, including mathematical modeling of disease progression, modeling of the behavior of biomarkers in the absence and presence of cancer, and measurement and analysis of costs and quality-of-life. The work of TOR investigators includes interventions for current patients, both preventing recurrence (for example, vaccines to prevent recurrence of ovarian cancer) and improving quality of life in cancer survivors. It includes intervention trials, both randomized and Phase I.

Dr. Urban is also the Program Head of the Gynecologic Cancer Research Program (GCRP) at the Fred Hutchinson Cancer Research Center.The GCRP focuses on improving clinical outcomes in patients with reproductive malignancies at every stage of disease. The themes of the program are (1) developing novel treatments based on identification of genetic alterations involved in the malignant transformation, (2) prevention of relapse and eventually primary disease using immunotherapeutic strategies, and (3) early detection of disease.

In Sept 1999, Dr. Urban and colleagues at five local collaborating research institutions were awarded an NCI Specialized Program of Research Excellence (SPORE) grant in ovarian cancer. Additionally, the group has established a well-characterized ovarian specimen repository housing over 6,000 individually identified specimens. The group has shared their findings with the broader research community through numerous presentations and publications.

Following are brief descriptions of four of the currently funded research projects for which Dr. Urban is the Principal Investigator.

The “Pacific Ovarian Cancer Research Consortium/SPORE in Ovarian Cancer” is a community-based, multidisciplinary, translational research program that involves clinicians, laboratory scientists and public health scientists from several research and medical institutions along thePacific Coast. The broad based approach takes full advantage of the scientific expertise available locally and allows the pooling of clinical resources, thus facilitating population-based studies despite the low incidence of ovarian cancer. POCRC scientists work on several different research projects, all aimed at increasing our understanding of ovarian cancer. The goals of these research projects include working toward: discovering genes that influence the responsiveness of ovarian cancer to chemotherapy treatments and using this information to improve treatment programs and outcomes for women with ovarian cancer, creating an ovarian cancer vaccine that would attack ovarian cancer cells as soon as they develop, developing a statistical model that can estimate a woman's risk for developing ovarian cancer, allowing investigators to target early detection and prevention efforts more efficiently, and refining and improving the use of blood tests used to detect ovarian cancer. The POCRC alsoincludes a Developmental Research Program and a Career Development Program.

For “Center for the Evaluation of Biomarkers for the Early Detection of Breast Cancer,” investigators from 10 institutions are working together to evaluate breast cancer biomarkers for their contribution to the early detection of breast cancer. The study’s ultimate goal is to define a biomarker panel that can be used in conjunction with current screening methods to improve early detection of all breast cancers, particularly aggressive cancers and those frequently missed by mammography. Blood and tissue specimens for biomarker analysis will be collected from women having annual mammograms and breast-related biopsies or surgery. This study utilizes the ongoing MammographyTumor Registry for Breast Cancer Research to follow participants throughout the study and monitor their mammography data and breast cancer outcomes.

“Modeling Ovarian Cancer Screening for CEA” seeks to improve the accuracy of a previously developed microsimulation model of ovarian cancer screening by accounting for heterogeneity in the disease and in the population screened, in order to evaluate the cost-effectiveness of using a marker panel longitudinally to detect developing disease. We will expand the scope of the model to accommodate use of (1) a panel of serum markers for screening and (2) risk-based screening. We will also incorporate QOL effects of both screening and disease, and update the model with respect to screening and treatment costs. These efforts will enable us to identify the potentially most efficient strategies for ovarian cancer screening and to report their cost-effectiveness.

“Validation of a Biomarker Panel for Early Detection of Breast Cancer in High-Risk Women” will investigate and validate promising biomarkers for their contribution to a marker panel that can be used for the early detection of breast cancer in high-risk women, particularly those with dense breasts or equivocal mammography findings who may benefit from MRI or PET. Once validated, this marker panel can be used to identify women for whom further imaging studies are indicated, and to reduce the rate of missed cancers and unnecessary biopsy in women undergoing mammography. The study also aims to provide a specimen resource to support both breast and ovarian cancer biomarker evaluation and validation. Investigators will build a unique resource for multidisciplinary, inter-institutional research on cancer biomarkers. This study is being conducted by researchers from FHCRC in collaboration with investigators at MD Anderson Cancer Center in Houston, Fox Chase Cancer Center in Philadelphia, and the University of Alabama, Birmingham.

Keywords

COS Keywords:

Biomarkers, Breast Cancer, Cancer Biology, Cancer Or Carcinogenesis, Health Care Economics, Ovarian Cancer.

Additional Terms:

Biomarkers, Breast Cancer, Cancer Screening, Cost-effective Analysis, Heath Economics, Mammography, Ovarian Cancer.

Memberships

American Public Health Association
American Society of Preventive Oncology
Association for Health Services Research
Society for Clinical Trials
Southwest Oncology Group

Previous Positions

1998-2005, Member, Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Cancer Prevention Research Program
1996-2005, Scientific Director, Marsha Rivkin Center for Ovarian Cancer Research

Funding Received

  • National Institutes of Health/National Cancer Institute: 'Validation of a Biomarker Panel for Early Detection of Breast Cancer in High-Risk Women', $144,494, Sep 30, 2002 to Sep 29, 2004.
  • National Institutes of Health (NIH): 'Pacific Ovarian Cancer Research Consortium' (SPORE in Ovarian Cancer), $1,727,230, Sep 30, 1999 to Sep 29, 2004.
  • National Institutes of Health (NIH): 'QOL Effects of Ovarian Cancer Risk Education and Screening', $429,005, Sep 15, 1997 to Jun 30, 2001.
  • National Institutes of Health/National Cancer Institute: 'Modeling Ovarian Cancer Screening for CEA', $175,000, Oct 1, 2002 to Sep 30, 2006.
  • Department of the Army: 'Use of Novel Technologies to ID and Investigate Molecular Markers for Ovarian Cancer Screening and Prevention', $779,293, Oct 1, 1998 to Sep 30, 2001.
  • Department of the Army: 'Center for the Evaluation of Biomarkers for the Early Detection of Breast Cancer', $1,114,579, Nov 1, 2002 to Oct 31, 2006.
  • National Institutes of Health (NIH): 'Use of Mammography Tumor Registry for Breast Cancer Research', $344,603, Jul 1, 1997 to Jun 30, 2001.

Publications

  • Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A (Sep 2005) Translational crossroads for biomarkers., Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 11 (17), 6103-8 Abstract
  • McIntosh MW, Drescher C, Karlan B, Scholler N, Urban N, Hellstrom KE, Hellstrom I (Oct 2004) Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma., Gynecologic Oncology, 95 (1), 9-15 Abstract
  • Andersen MR, Urban N, Ramsey S, Briss PA (Sep 2004) Examining the cost-effectiveness of cancer screening promotion., Cancer, 101 (5 Suppl), 1229-38 Abstract
  • Andersen MR, Nelson J, Peacock S, Giedzinska A, Dresher C, Bowen D, Urban N (Aug 2004) Worry about ovarian cancer risk and use of screening by high-risk women: how you recruit affects what you find., American Journal of Medical Genetics. Part a, 129A (2), 130-5 Abstract
  • Drescher CW, Nelson J, Peacock S, Andersen MR, McIntosh MW, Urban N (Apr 2004) Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening., Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 13 (4), 600-6 Abstract
  • Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE (Sep 2003) Mammography surveillance following breast cancer., Breast Cancer Research and Treatment, 81 (2), 107-15 Abstract
  • Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Orsulic S, Smyth J, Ursulic S ( Sep 2003) Current research and treatment for epithelial ovarian cancer. A PositionPaper from the Helene Harris Memorial Trust, , , 1818-27 pages
  • Urban N, McIntosh MW, Andersen M, Karlan BY (Aug 2003) Ovarian cancer screening., Hematology/oncology Clinics of North America, 17 (4), 989-1005, ix Abstract
  • Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellstrom KE (Jul 2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma., Cancer Research, 63 (13), 3695-700 Abstract
  • Andersen MR, Smith R, Meischke H, Bowen D, Urban N (Apr 2003) Breast cancer worry and mammography use by women with and without a family history in a population-based sample., Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 12 (4), 314-20 Abstract
  • Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (Apr 2003) The case for early detection., Nature Reviews. Cancer, 3 (4), 243-52 Abstract
  • McIntosh MW, Urban N, A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker, Biostatistics, 3(4), 27-40, March 2003
  • Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH (Mar 2003) Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q., International Journal of Cancer. Journal International Du Cancer, 104 (1), 73-84 Abstract
  • Urban N (Jan 2003) Specific keynote: ovarian cancer risk assessment and the potential for early detection., Gynecologic Oncology, 88 (1 Pt 2), S75-9; discussion S8 Abstract
  • Andersen MR, Hager M, Su C, Urban N, Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities, Health Education and Behavior, 29(6), 755-70, December 2002
  • Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA at al., Detection of ductal carcinoma in situ in women undergoing screening mammography, Journal of the National Cancer Institute, 94(20), 1546-54, 16 Oct 2002
  • Thompson B, Thompson LA, Andersen MR, Hager S, Taylor V, Urban N, Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital, Preventive Medicine, 35(1), 87-96, July 2002 Abstract
  • Lehman C, Holt S, Peacock S, White E, Urban N, Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms, AJR American Journal of Roentgenology, 179(1), 15-20, July 2002 Abstract
  • Urban N, Developing measures of mammography performance, Medical Care, 40(6 Suppl), III86-8, June 2002 Abstract
  • Andersen MR, Peacock S, Nelson J, Wilson S, McIntosh M, Drescher C, Urban N, Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer, Gynecologic Oncology, 85(1), 3-8, April 2002 Abstract
  • Taplin SH, Ichikawa LE, Kerlikowske K, Ernster VL, Rosenberg RD, Yankaskas BC, Carney PA, Geller BM, Urban N, Dignan MB, Barlow WE, Ballard-Barbash R, Sickles EA, Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography, Radiology, 222(2), 529-35, February 2002 Abstract
  • McIntosh MW, Urban N, Karlan B, Generating longitudinal screening algorithms using novel biomarkers for disease, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 11(2), 159-66, February 2002 Abstract
  • Meischke H, Kuniyuki A, Yasui Y, Bowen DJ, Andersen MR, Urban N, Information women receive about heart attacks and how it affects their knowledge, beliefs, and intentions to act in a cardiac emergency, Health Care for Women International, 23(2), 149-62, February 2002
  • Stoddard AM, Fox SA, Costanza ME, Lane DS, Andersen MR, Urban N, Lipkus I, Rimer BK., Effectiveness of telephone counseling for mammography: results from five randomized trials, Preventive Medicine, 34, 90-9, 2002
  • Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G., Early detection of ovarian cancer: promise and reality, Cancer Treatment and Research, 107, 61-97, 2002
  • Geller BW, Barlow WE, Ballard-Barbash R, Ernster VL, Yankaskas BC, Sickles EA, Carney PA, Dignan MB, Rosenberg RD, Urban N, Zheng Y, Taplin SH, Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease, Radiology, 222(2), 536-42, 2002
  • Ramsey SD, Clarke L, Berry K, Higashi M, Urban N, Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer, Annals of Internal Medicine, 135(8 Pt. 1), 577-88, 16 Oct 2001
  • Stone B, Schummer M, Paley PJ, Crawford M, Ford M, Urban N, Nelson BH, MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily, Gene, 267(2), 173-82, 18 Apr 2001
  • McIntosh MW, Ramsey S, Berry K, Urban N, Parameter solicitation for planning cost-effectivenss studies with dichotomous outcomes, Health Economics, 10(1), 53-66, Jan 2001
  • Kerlikowske K, Carney P, Geller B, Mandelson M, Taplin S, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R., Performance of screening mammography among women with and without a first-degree relative with breast cancer, Annals of Internal Medicine, 133(11), 5 Dec 2000
  • Rosenberg RD, Yankaskas BC, Hunt WC, Ballard-Barbash R, Urban N, Ernster VL, Kerlikowske K, Geller B, Carney PA, Taplin S, Effects of variations in operational definitions on performance estimates for screening mammography, Academic Radiology, 7(12), 1058-68, December 2000
  • Crump KC, McIntosh MW, Urban N, Anderson G, Karlan B, Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening, Cancer Epidemiology, Biomarkers and Prevention, 9(10), 1107-11, October 2000
  • Bowen DJ, Andersen MR, Urban N, Volunteerism in a community-based sample of women, aged 50 to 80 years, Journal of Applied Psychology, 30(9), 1829-42, September 2000
  • Carney PA, Geller BM, Moffett H, Ganger M, Sewell M, Barlow WE, Stalnaker N, Taplin SH, Sisk C, Ernster VL, Wilkie HA. Yankaskas B, Poplack SP, Urban N, West MM, Rosenberg RD, Michael S, Mercurio TD, Ballard-Barbash R, Current medicolegal and confidentiality issues in large, multicenter research programs, American Journal of Epidemiology, 152(4), 371-8, 15 Aug 2000
  • Ramsey SD, McIntosh M, Etzioni R, Urban N, Simulation modeling of outcomes and cost-effectiveness [Review], Hematology/Oncology Clinics of North America, 14(4), 925-38, August 2000
  • Drescher C, Holt SK, Andersen MR, Anderson G, Urban N, Use of ovarian cancer screening among a general population sample in Washington State, Obstetrics and Gynecology, 96(1), 70-4, July 2000
  • Andersen MR, Yasui Y, Meischke H, Kuniyuki A, Etzioni R, Urban N, The effectiveness of mammography promotion by volunteers in rural communities, American Journal of Preventative Medicine, 18(3), 199-207, April 2000
  • Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, Urban N, Quality of life in survivors of colorectal carcinoma, Cancer, 88(6), 1294-303, 15 Mar 2000
  • Andersen MR, Hager M, Meischke H, Shaw C, Yasui Y, Urban N, Recruitment, retention and activity of volunteers promoting mammography use in rural communities, Health Promotion Practice, 1(4), 341-50, 2000
  • Lehman CD, White E, Peacock S, Drucker MJ, Urban N, Effect of age and breast density on screening mammograms with false-positive findings, American Journal of Roentgenology, 173(6), 1651-5, December 1999
  • Meischke H, Yasui Y, Kuniyuki A, Bowen DJ, Andersen R, Urban N, How women label and respond to symptoms of acute myocardial infarction: responses to hypothetical symptom scenarios, Heart and Lung, 28(4), 261-9, July 1999
  • Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N, Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?, American Journal of Preventive Medicine, 17(1), 87-90, July 1999 Abstract
  • Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N, Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?, American Journal of Preventive Medicine, 17(1), 87-90, July 1999 Abstract
  • Desnick L, Taplin S, Taylor V, Coole D, Urban N, Clinical breast examination in primary care: perceptions and predictors among three specialties, Journal of Womens Health, 8(3), 389-97, April 1999 Abstract
  • Desnick L, Taplin S, Taylor V, Coole D, Urban N, Clinical breast examination in primary care: perceptions and predictors among three specialties., Journal of Womens Health, 8(3), 389-97, April 1999 Abstract
  • Andersen MR, Urban N., Involvement in decision making and breast cancer survivor quality of life, Annals of Behavioral Medicine, 21(3), 201-209, 1999
  • Urban, N., Screening for ovarian cancer, British Medical Journal, 319(7221), 1317-1318, 1999
  • Andersen MR, Urban N, Etzioni R., Community attitudes and mammography use: Does it really matter what other people think?, Women and Health, 29(3), 83-93, 1999
  • Meischke H, Andersen R, Bowen D, Kuniyuki A, Urban N, A health priorities model: application to mammography screening., Health Education and Behavior, 25(3), 383-95, June 1998 Abstract
  • Stoddard A M, Rimer B K, Lane D, Fox S A, Lipkus I, Luckmann R, Avrunin J S, Sprachman S, Costanza M, Urban N, Underusers of mammogram screening: stage of adoption in five U.S. subpopulations. The NCI Breast Cancer Screening Consortium., Preventive Medicine, 27(3), 478-87, May 1998 Abstract
  • Stoddard AM, Rimer BK, Lane DS, Fox SA, Lipkus I, Luckmann R, Avrunin JS, Sprachman S, Costanza M, Urban N for the NCI Breast Cancer Consortium, Under-users mammogram screening: stage of adoption in five U.S. sub-populations, Preventive Medicine, 27(3), 478-487, 1998
  • Meischke H, Andersen R, Urban N, A health priorities model: Application to mammography screening, Health Education and Behavior, 25(3), 383 - 395, 1998
  • Lewis CE, George V, Fouad M, Porter V, Bowen D, Urban N, Recruitment strategies in the Women's Health Trial: Feasibility Study in Minority Populations, Controlled Clinical Trials, 461 - 476, 1998
  • Pepe M S, Urban N, Rutter C, Longton G, Design of a study to improve accuracy in reading mammograms, Journal of Clinical Epidemiology, 50(12), 1327-38, December 1997 Abstract
  • Ballard-Barbash R, Taplin S H, Yankaskas B C, Ernster V L, Rosenberg R D, Carney P A, Barlow W E, Geller B M, Kerlikowske K, Edwards B K, Lynch C F, Urban N, Chrvala C A, Key C R, Poplack S P, Worden J K, Kessler L G, Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database., American Journal of Roentgenology, 169(4), 1001-8, October 1997 Abstract
  • Ramsey SD, Etzioni R, Troxel A, Urban N, Optimizing sampling strategies for estimating quality-adjusted life years., Medical Decision Making, 17(4), 431-8, October 1997 Abstract
  • Ramsey S D, Etzioni R, Troxel A, Urban N, Optimizing sampling strategies for estimating quality-adjusted life years, Medical Decision Making, 17(4), 431-8, Autumn 1997 Abstract
  • Rakowski W, Andersen M R, Stoddard A M, Urban N, Rimer B K, Lane D S, Fox S A, Costanza M E, Confirmatory analysis of opinions regarding the pros and cons of mammography., Health Psychology, 16(5), 433-41, September 1997 Abstract
  • Urban N, Drescher C, Etzioni R, Colby C, Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening, Controlled Clinical Trials, 18(3), 251-70, June 1997 Abstract
  • Taplin S H, Urban N, Taylor V M, Savarino J, Conflicting national recommendations and the use of screening mammography: does the physician's recommendation matter?, Journal of The American Board of Family Practice, 10(2), 88-95, Spring 1997 Abstract
  • Andersen M R, Urban N, Physician gender and screening: do patient differences account for differences in mammography use?, Women and Health, 26(1), 29-39, 1997 Abstract
  • Urban N, Drescher C, Clarke L, Kiviat N., Cost-effectiveness analysis of ovarian cancer screening strategies, Hungarian Journal of Gynecological Oncology (in Hungarian), 169-180, 1997
  • Urban N, Drescher C, Etzioni R, Colby C., Use of a stochastic simulation model to identify an efficient strategy for ovarian cancer screening, Controlled Clinical Trials, 18, 251 - 270, 1997
  • Bowen D, Clifford C K, Coates R, Evans M, Feng Z, Fouad M, George V, Gerace T, Grizzle J E, Hall W D, Hearn M, Henderson M, Kestin M, Kristal A, Leary E T, Lewis C E, Oberman A, Prentice R, Raczynski J, Toivola B, Urban N, The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions., Annals of Epidemiology, 6(6), 507-19, November 1996 Abstract
  • Taylor V M, Taplin S H, Urban N, White E, Mahloch J, Majer K, McLerran D, Peacock S, Community organization to promote breast cancer screening ordering by primary care physicians, Journal of Community Health, 21(4), 277-91, August 1996 Abstract
  • Etzioni R, Urban N, Baker M, Estimating the costs attributable to a disease with application to ovarian cancer, Journal of Clinical Epidemiology, 49(1), 95-103, January 1996 Abstract
  • Urban N, Taplin S H, Taylor V M, Peacock S, Anderson G, Conrad D, Etzioni R, White E, Montano D E, Mahloch J, et al, Community organization to promote breast cancer screening among women ages 50-75, Preventive Medicine, 24(5), 477-84, September 1995 Abstract
  • Taylor V M, Taplin S H, Urban N, White E, Peacock S, Repeat mammography use among women ages 50-75, Cancer Epidemiology, Biomarkers and Prevention, 4(4), 409-13, June 1995 Abstract
  • Taplin S H, Barlow W, Urban N, Mandelson M T, Timlin D J, Ichikawa L, Nefcy P, Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care, Journal of The National Cancer Institute, 87(6), 417-26, 15 Mar 1995 Abstract
  • Taplin S H, Taylor V, Montano D, Chinn R, Urban N, Specialty differences and the ordering of screening mammography by primary care physicians, Journal of The American Board of Family Practice, 7(5), 375-86, Autumn 1994 Abstract
  • Taylor V M, Taplin S H, Urban N, Mahloch J, Majer K A, Medical community involvement in a breast cancer screening promotional project, Public Health Reports, 109(4), 491-9, Summer 1994 Abstract
  • Urban N, Anderson G L, Peacock S, Mammography screening: how important is cost as a barrier to use?, American Journal of Public Health, 84(1), 50-5, January 1994 Abstract
  • Thornquist M D, Urban N, Tseng A, Edelstein C, Lund B, Omenn G S, Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy Trial, Controlled Clinical Trials, 14(4), 325-39, August 1993 Abstract
  • Urban N, Anderson G L, Tseng A, Effects on response rates and costs of stamps vs business reply in a mail survey of physicians, Journal of Clinical Epidemiology, 46(5), 455-9, May 1993 Abstract
  • White E, Urban N, Taylor V, Mammography utilization, public health impact, and cost-effectiveness in the United States, Annual Review of Public Health, 14, 605-33, 1993 Abstract
  • Kristal A R, White E, Shattuck A L, Curry S, Anderson G L, Fowler A, Urban N, Long-term maintenance of a low-fat diet: durability of fat-related dietary habits in the Women's Health Trial, Journal of The American Dietetic Association, 92(5), 553-9, May 1992 Abstract
  • Urban N, White E, Anderson G L, Curry S, Kristal A R, Correlates of maintenance of a low-fat diet among women in the Women's Health Trial, Preventive Medicine, 21(3), 279-91, May 1992 Abstract
  • White E, Shattuck A L, Kristal A R, Urban N, Prentice R L, Henderson M M, Insull W Jr, Moskowitz M, Goldman S, Woods M N, Maintenance of a low-fat diet: follow-up of the Women's Health Trial, Cancer Epidemiology, Biomarkers and Prevention, 1(4), 315-23, Spring 1992 Abstract
  • White E, Hurlich M, Thompson R S, Woods M N, Henderson M M, Urban N, Kristal A, Dietary changes among husbands of participants in a low-fat dietary intervention., American Journal of Preventive Medicine, 7(5), 319-25, Autumn 1991 Abstract
  • Schapira D V, Urban N, A minimalist policy for breast cancer surveillance, Jama, 265(3), 380-2, 16 Jan 1991 Abstract
  • Baker M S, Kessler L G, Urban N, Smucker R C, Estimating the treatment costs of breast and lung cancer, Medical Care, 29(1), 40-9, January 1991 Abstract
  • Urban N, Self S, Kessler L, Prentice R, Henderson M, Iverson D, Thompson D, Byar D, Insull W, Gorbach S L, et al, Analysis of the costs of a large prevention trial, Controlled Clinical Trials, 11(2), 129-46, April 1990 Abstract
  • Paskett E D, White E, Urban N, Gey G O, Hornecker J, Meadows S, Sifferman F R, Implementation and evaluation of a worksite breast self-examination training program, Progress In Clinical and Biological Research, 339, 281-302, 1990 Abstract
  • Andersen MR, Urban N, Involvement in decision making and breast cnacer survivor quality of life, Annals of Behavioral Medicine
  • Andersen MR, Holt S, Meisschke H, Bowen D, Yasui Y, Urban N, Breast cancer worry and mammography use by women with and without a family history in a population-based sample, Cancer Epidemiology, Biomarkers and Prevention
  • Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH, Serological analysis of ovarian tumor antigens reveals a bias towards antigens encoded on 17q, International Journal of Cancer

Profile Details

Last Updated: 9/4/2008

COS Expertise ID #373598
Reference this profile directly: http://myprofile.cos.com/urbann98